VYTORIN Side Effects

6861373-3 | Acute Myocardial Infarction, Blood Pressure Inadequately Controlled, Dizziness, Dyslipidaemia, Dysphagia, Dyspnoea, Thyroxine Increased
on Oct 13, 2007 Male patient from PHILIPPINES , 49 years of age, was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, blood pressure inadequately controlled, dizziness (What is dizziness?), dyslipidaemia, dysphagia, dyspnoea, thyroxine increased. Vytorin dosage: 10-20 Mg/daily, Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ), PROPYLTHIOURACIL (View Propylthiouracil Review and Propylthiouracil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6846946-6 | Myocardial Infarction
Patient was taking Vytorin (View Usage). Patient had the following side effects: myocardial infarction on Jul 06, 2010 from PHILIPPINES Additional patient health information: Male patient , 58 years of age, . Vytorin dosage: 10-20 Mg/daily/po. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).

6846945-4 | Myocardial Infarction
Adverse event was reported on Jul 06, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: 10-20 Mg/daily/ Po) . Location: PHILIPPINES , 58 years of age, After Vytorin was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).

6844103-0 | Abdominal Distension, Abdominal Pain, Constipation, Diarrhoea, Faeces Discoloured, Hepatic Pain, Malaise, Steatorrhoea
on Jul 07, 2010 Female patient from BRAZIL , 57 years of age, weighting 154.3 lb, was diagnosed with ill-defined disorder, pancreatic insufficiency and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), constipation (What is constipation?), diarrhoea, faeces discoloured, hepatic pain, malaise, steatorrhoea. Vytorin dosage: Daily Dose: 1 Dosage Form. During the same period patient was treated with CREON (Daily Dose: 9 Dosage Form) (View Creon Review and Creon Label ).


6843423-3 | Myocardial Infarction
on Nov 14, 2007 Male patient from PHILIPPINES , 58 years of age, was treated with Vytorin (View Usage). Patient had the following side effects: myocardial infarction. Vytorin dosage: 10-20 Mg/daily Po. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).

6841799-4 | Cytolytic Hepatitis, Rhabdomyolysis
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: cytolytic hepatitis, rhabdomyolysis on Jul 12, 2010 from FRANCE Additional patient health information: Female patient , 78 years of age, was diagnosed with hypercholesterolaemia and. Vytorin dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), NEBIVOLOL HYDROCHLORIDE (View Nebivolol Hydrochloride Review and Nebivolol Hydrochloride Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6837451-1 | Haemorrhage
Adverse event was reported on Jul 09, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: ITALY , 73 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhage. During the same period patient was treated with CAPTOPRIL (View Captopril Review and Captopril Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), OMEGA 3 ACID ETHYL ESTERS (View Omega-3 Acid Ethyl Esters Review and Omega-3 Acid Ethyl Esters Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6818834-2 | Blood Ph Decreased, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Cough, Dyspnoea, Exercise Tolerance Decreased, Influenza Like Illness, Lower Respiratory Tract Infection, Sputum Discoloured
on Jun 11, 2010 Male patient from UNITED KINGDOM , 65 years of age, weighting 176.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient had the following side effects: blood ph decreased, chronic obstructive pulmonary disease, condition aggravated, cough, dyspnoea, exercise tolerance decreased, influenza like illness, lower respiratory tract infection, sputum discoloured. Vytorin dosage: 10-40 Mg/daily/po. During the same period patient was treated with BISOPROLOL (1.25 Mg/daily/po) (View Bisoprolol Review and Bisoprolol Label ), CLARITHROMYCIN (1000 Mg/daily/po) (View Clarithromycin Review and Clarithromycin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SERETIDE (View Seretide Review and Seretide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6817848-6 | Alopecia, Complex Regional Pain Syndrome, Gait Disturbance, Movement Disorder, Muscle Disorder, Myalgia, Nerve Injury, Nerve Root Compression
on Jun 30, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with blood cholesterol increased and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: alopecia, complex regional pain syndrome (What is complex regional pain syndrome?), gait disturbance, movement disorder (What is movement disorder?), muscle disorder (What is muscle disorder?), myalgia, nerve injury, nerve root compression. Vytorin dosage: . During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), MANTAI (View Mantai Review and Mantai Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALTACE (View Altace Review and Altace Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized and became disabled.

6815756-8 | Accident At Home, Coagulopathy, Liver Function Test Abnormal, Mental Status Changes, Myocardial Infarction, Renal Failure Acute, Respiratory Failure, Rhabdomyolysis, Toxic Encephalopathy
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: accident at home, coagulopathy, liver function test abnormal, mental status changes, myocardial infarction, renal failure acute, respiratory failure, rhabdomyolysis, toxic encephalopathy on Jun 28, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Vytorin dosage: . During the same period patient was treated with FLAVOXATE HYDROCHLORIDE (1-3 Times Daily) (View Flavoxate Hydrochloride Review and Flavoxate Hydrochloride Label ), ALTACE (View Altace Review and Altace Label ), LYRICA (View Lyrica Review and Lyrica Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLBEE (View Folbee Review and Folbee Label ), BACLOFEN (2-3 Times Daily) (View Baclofen Review and Baclofen Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6813745-0 | Renal Failure, Rhabdomyolysis
Adverse event was reported on Jun 29, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with coronary artery disease (What is coronary artery disease?) and. Location: GERMANY , 62 years of age, weighting 220.5 lb, Patient had the following side effects: renal failure, rhabdomyolysis. Patient was hospitalized.

6813741-3 | Iron Deficiency Anaemia
on Jun 30, 2010 Female patient from ITALY , 76 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: iron deficiency anaemia. Vytorin dosage: . Patient was hospitalized.

6811330-8 | Coronary Artery Disease, Joint Dislocation, Myalgia, Myocardial Infarction, Rib Fracture, Road Traffic Accident
on Jun 24, 2010 Male patient from UNITED STATES , 62 years of age, weighting 165.3 lb, was diagnosed with blood cholesterol increased, stent placement and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), joint dislocation, myalgia, myocardial infarction, rib fracture, road traffic accident. Vytorin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), TYLENOL (View Tylenol Review and Tylenol Label ), OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ), CHONDROITIN SULFATE SODIUM AND GLUCOSAMINE SULFATE (View Chondroitin Sulfate Sodium And Glucosamine Sulfate Review and Chondroitin Sulfate Sodium And Glucosamine Sulfate Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

6804532-8 | Cytolytic Hepatitis, Rhabdomyolysis
Patient was taking Vytorin (View Usage). Patient had the following side effects: cytolytic hepatitis, rhabdomyolysis on Jun 23, 2010 from FRANCE Additional patient health information: Female patient , 78 years of age, was diagnosed with hypercholesterolaemia and. Vytorin dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), NEBIVOLOL HYDROCHLORIDE (View Nebivolol Hydrochloride Review and Nebivolol Hydrochloride Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6800564-4 | Dysstasia, Pain In Extremity
Adverse event was reported on Jun 28, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: 10/20 1 Per Day By Mouth) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 78 years of age, weighting 175.0 lb, After Vytorin was administered, patient had the following side effects: dysstasia, pain in extremity.

6800356-6 | Nephrolithiasis, White Blood Cell Count Increased
on Jun 17, 2010 Male patient from UNITED KINGDOM , 56 years of age, weighting 132.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis, white blood cell count increased. Vytorin dosage: 10/40 Mg/daily/po. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6799501-0 | Asthma, Blood Ph Decreased, Blood Urea Increased, Chronic Obstructive Pulmonary Disease, Exercise Tolerance Decreased, Hypotension, Influenza Like Illness, Lower Respiratory Tract Infection, Lymphocyte Count Decreased
on Jun 11, 2010 Male patient from UNITED KINGDOM , 65 years of age, weighting 176.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient had the following side effects: asthma (What is asthma?), blood ph decreased, blood urea increased, chronic obstructive pulmonary disease, exercise tolerance decreased, hypotension, influenza like illness, lower respiratory tract infection, lymphocyte count decreased. Vytorin dosage: 10-40 Mg/daily/po. During the same period patient was treated with BISOPROLOL UNK (1.25 Mg/daily/po) (View Bisoprolol Unk Review and Bisoprolol Unk Label ), CLARITHROMYCIN (1000 Mg/daily/po) (View Clarithromycin Review and Clarithromycin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SERETIDE (View Seretide Review and Seretide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ). Patient was hospitalized and became disabled.

6797356-1 | Nephrolithiasis, White Blood Cell Count Increased
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: nephrolithiasis, white blood cell count increased on Jun 11, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, weighting 132.0 lb, was diagnosed with acute coronary syndrome and. Vytorin dosage: 10/40 Mg/daily/po. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6796919-7 | Breast Cancer Female, Breast Cancer Metastatic, Inflammatory Carcinoma Of The Breast, Lymphadenopathy, Metastases To Liver, Metastases To Lung, Metastases To Spine, Neck Pain
Adverse event was reported on Jun 11, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: Po) was diagnosed with acute coronary syndrome and. Location: COLOMBIA , 53 years of age, weighting 123.0 lb, Patient experienced the following unwanted or unexpected effects: breast cancer female, breast cancer metastatic, inflammatory carcinoma of the breast, lymphadenopathy, metastases to liver, metastases to lung, metastases to spine, neck pain. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6796267-5 | Iron Deficiency Anaemia
on Jun 22, 2010 Female patient from ITALY , 76 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). Patient had the following side effects: iron deficiency anaemia. Vytorin dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6796265-1 | Abasia, Muscular Weakness
on Jun 17, 2010 Male patient from UNITED STATES , 80 years of age, was diagnosed with blood cholesterol increased and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: abasia, muscular weakness. Vytorin dosage: . Patient was hospitalized.

6795639-2 | Asthenia, Blood Creatine Phosphokinase Increased, Cardiac Arrest, Fatigue, Hyperkalaemia, Renal Failure Acute, Rhabdomyolysis
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatine phosphokinase increased, cardiac arrest (What is cardiac arrest?), fatigue, hyperkalaemia, renal failure acute, rhabdomyolysis on Jun 15, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 176.4 lb, was diagnosed with hyperlipidaemia and. Vytorin dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), NORTRIPTYLINE (View Nortriptyline Review and Nortriptyline Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE (View Guaifenesin And Phenylephrine Hydrochloride Review and Guaifenesin And Phenylephrine Hydrochloride Label ). Patient was hospitalized and became disabled.

6792445-X | Cytolytic Hepatitis, Rhabdomyolysis
Adverse event was reported on Jun 22, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: FRANCE , 78 years of age, Patient had the following side effects: cytolytic hepatitis, rhabdomyolysis. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), NEBIVOLOL HYDROCHLORIDE (View Nebivolol Hydrochloride Review and Nebivolol Hydrochloride Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6785246-X | Asthenia, Back Pain, Blood Pressure Increased, Chest Pain, Fatigue, Gastrooesophageal Reflux Disease, Loss Of Consciousness, Neck Pain, Pain In Extremity
on Jun 22, 2010 Female patient from UNITED STATES , 55 years of age, weighting 160.0 lb, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: asthenia, back pain (What is back pain?), blood pressure increased, chest pain (What is chest pain?), fatigue, gastrooesophageal reflux disease, loss of consciousness, neck pain, pain in extremity. Vytorin dosage: 1 Tablet At Bedtime. Patient was hospitalized.

6785205-7 | Amnesia, Depression, Disturbance In Attention, Dizziness, Hallucination, Auditory, Impaired Work Ability, Insomnia, Nausea, Pharyngeal Oedema
on Jun 22, 2010 Male patient from UNITED STATES , weighting 192.5 lb, was diagnosed with blood cholesterol increased and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, depression (What is depression?), disturbance in attention, dizziness (What is dizziness?), hallucination, auditory, impaired work ability, insomnia, nausea (What is nausea?), pharyngeal oedema. Vytorin dosage: Vytorin 10/80 1 Daily.

6782140-5 | Asthenia, Blood Creatine Phosphokinase Increased, Cardiac Arrest, Fatigue, Hyperkalaemia, Renal Failure Acute, Rhabdomyolysis
Patient was taking Vytorin (View Usage). Patient had the following side effects: asthenia, blood creatine phosphokinase increased, cardiac arrest (What is cardiac arrest?), fatigue, hyperkalaemia, renal failure acute, rhabdomyolysis on Jun 15, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 176.4 lb, was diagnosed with hyperlipidaemia and. Vytorin dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), NORTRIPTYLINE (View Nortriptyline Review and Nortriptyline Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE (View Guaifenesin And Phenylephrine Hydrochloride Review and Guaifenesin And Phenylephrine Hydrochloride Label ). Patient was hospitalized and became disabled.

6771132-8 | Dysstasia, Gait Disturbance, Muscle Spasms, Pain, Rhabdomyolysis
Adverse event was reported on Jun 14, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: 10 - 20 Mg 1-daily) was diagnosed with low density lipoprotein and. Location: UNITED STATES , weighting 140.0 lb, After Vytorin was administered, patient had the following side effects: dysstasia, gait disturbance, muscle spasms, pain (What is pain?), rhabdomyolysis.

6768193-9 | Cardiac Arrest, Myocardial Infarction, Renal Failure, Rhabdomyolysis
on Jun 09, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), myocardial infarction, renal failure, rhabdomyolysis. Vytorin dosage: . Patient was hospitalized.

6768192-7 | Periarthritis
on May 31, 2010 Male patient from SWITZERLAND , 53 years of age, was diagnosed with hyperlipidaemia and was treated with Vytorin (View Usage). Patient had the following side effects: periarthritis. Vytorin dosage: .

6764302-6 | Cholecystitis, Gallbladder Disorder, Pancreatitis
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: cholecystitis, gallbladder disorder, pancreatitis on Jun 03, 2010 from AUSTRALIA Additional patient health information: Female patient , 63 years of age, was diagnosed with dyslipidaemia and. Vytorin dosage: . Patient was hospitalized.

6762611-8 | Alopecia, Complex Regional Pain Syndrome, Gait Disturbance, Movement Disorder, Muscle Disorder, Myalgia, Nerve Injury, Nerve Root Compression
Adverse event was reported on Jun 02, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: alopecia, complex regional pain syndrome (What is complex regional pain syndrome?), gait disturbance, movement disorder (What is movement disorder?), muscle disorder (What is muscle disorder?), myalgia, nerve injury, nerve root compression. During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), APRESOLINE (View Apresoline Review and Apresoline Label ), HUMALOG (View Humalog Review and Humalog Label ), MANTAI (View Mantai Review and Mantai Label ), ZOCOR (View Zocor Review and Zocor Label ), ALTACE (View Altace Review and Altace Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized and became disabled.

6754284-5 | Asthenia, Blood Creatine Phosphokinase Increased, Cardiac Arrest, Fatigue, Hyperkalaemia, Renal Failure Acute, Rhabdomyolysis
on May 25, 2010 Female patient from UNITED STATES , 72 years of age, weighting 176.4 lb, was diagnosed with hyperlipidaemia and was treated with Vytorin (View Usage). Patient had the following side effects: asthenia, blood creatine phosphokinase increased, cardiac arrest (What is cardiac arrest?), fatigue, hyperkalaemia, renal failure acute, rhabdomyolysis. Vytorin dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE (View Guaifenesin And Phenylephrine Hydrochloride Review and Guaifenesin And Phenylephrine Hydrochloride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized and became disabled.

6754271-7 | Asthma
on May 28, 2010 Male patient from UNITED KINGDOM , weighting 207.2 lb, was diagnosed with hypercholesterolaemia, asthma (What is asthma?) and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: asthma (What is asthma?). Vytorin dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (View Fluticasone Propionate And Salmeterol Xinafoate Review and Fluticasone Propionate And Salmeterol Xinafoate Label ), ZOCOR (View Zocor Review and Zocor Label ).

6752741-9 | Bladder Transitional Cell Carcinoma, Urinary Tract Disorder, Urinary Tract Obstruction
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: bladder transitional cell carcinoma, urinary tract disorder, urinary tract obstruction on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 220.0 lb, was diagnosed with acute coronary syndrome and. Vytorin dosage: 1 Tab Daily Po. During the same period patient was treated with NITROSTAT (View Nitrostat Review and Nitrostat Label ), PLAVIX (View Plavix Review and Plavix Label ), ZANTAC (View Zantac Review and Zantac Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN (View Metformin Review and Metformin Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ).

6752021-1 | Alopecia, Complex Regional Pain Syndrome, Gait Disturbance, Movement Disorder, Muscle Disorder, Myalgia, Nerve Injury, Nerve Root Compression
Adverse event was reported on May 27, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: alopecia, complex regional pain syndrome (What is complex regional pain syndrome?), gait disturbance, movement disorder (What is movement disorder?), muscle disorder (What is muscle disorder?), myalgia, nerve injury, nerve root compression. During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), APRESOLINE (View Apresoline Review and Apresoline Label ), HUMALOG (View Humalog Review and Humalog Label ), MANTAI (View Mantai Review and Mantai Label ), ZOCOR (View Zocor Review and Zocor Label ), ALTACE (View Altace Review and Altace Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized and became disabled.

6738922-9 | Cardiac Disorder, Gastric Disorder, Joint Swelling, Musculoskeletal Stiffness, Myalgia
on May 18, 2010 Male patient from UNITED STATES , 65 years of age, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: cardiac disorder, gastric disorder, joint swelling, musculoskeletal stiffness, myalgia. Vytorin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PREVACID (View Prevacid Review and Prevacid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6738040-X | Bladder Transitional Cell Carcinoma, Prostate Cancer
on May 07, 2010 Male patient from UNITED STATES , 62 years of age, weighting 220.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: bladder transitional cell carcinoma, prostate cancer (What is prostate cancer?). Vytorin dosage: 1 Tab/daily/po. During the same period patient was treated with NITROSTAT (View Nitrostat Review and Nitrostat Label ), PLAVIX (View Plavix Review and Plavix Label ), ZANTAC (View Zantac Review and Zantac Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ).

6735153-3 | Myalgia
Patient was taking Vytorin (View Usage). Patient had the following side effects: myalgia on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 215.0 lb, was diagnosed with blood cholesterol, blood triglycerides increased and. Vytorin dosage: 10/20 Mg 1 Tab Daily In P.m..

6732403-4 | Alanine Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Fatigue, Myalgia
Adverse event was reported on May 10, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) . Location: AUSTRALIA , 60 years of age, After Vytorin was administered, patient had the following side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, fatigue, myalgia. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

6729738-8 | Blood Calcium Decreased, Nephrolithiasis, Platelet Count Increased
on Apr 30, 2010 Male patient from UNITED KINGDOM , 56 years of age, weighting 132.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium decreased, nephrolithiasis, platelet count increased. Vytorin dosage: 10/40 Mg/daily/po. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6726048-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Cardiac Failure, Pneumonia, Rhabdomyolysis
on May 12, 2010 Male patient from GERMANY , 81 years of age, weighting 152.1 lb, was diagnosed with coronary artery disease (What is coronary artery disease?), arterial bypass operation, pneumonia (What is pneumonia?) and was treated with Vytorin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure, pneumonia (What is pneumonia?), rhabdomyolysis. Vytorin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ).

6724716-7 | Arthralgia, Arthritis, Contusion, Dysphagia, Joint Swelling, Muscle Strain, Myalgia, Spinal Disorder
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: arthralgia, arthritis (What is arthritis?), contusion, dysphagia, joint swelling, muscle strain, myalgia, spinal disorder on May 12, 2010 from GERMANY Additional patient health information: Male patient , 50 years of age, weighting 194.0 lb, was diagnosed with hypercholesterolaemia, coronary artery disease (What is coronary artery disease?) and. Vytorin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ISDN (View Isdn Review and Isdn Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), MADOPAR (View Madopar Review and Madopar Label ). Patient was hospitalized.

6724224-3 | Breast Cancer, Joint Swelling, Oedema Peripheral, Swelling Face, Swollen Tongue
Adverse event was reported on May 11, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 79 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), joint swelling, oedema peripheral, swelling face, swollen tongue. During the same period patient was treated with ZEGERID (View Zegerid Review and Zegerid Label ).

6724220-6 | Blood Creatinine Increased, Myositis, Quadriparesis, Respiratory Failure, Vitamin D Deficiency
on May 10, 2010 Female patient from AUSTRALIA , 62 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Vytorin (View Usage). Patient had the following side effects: blood creatinine increased, myositis (What is myositis?), quadriparesis, respiratory failure, vitamin d deficiency. Vytorin dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6711897-4 |
on May 03, 2010 Male patient from ITALY , 53 years of age, was diagnosed with hypercholesterolaemia, type 2 diabetes mellitus and was treated with Vytorin (View Usage). . Vytorin dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6702850-5 | Abdominal Distension, Abdominal Pain Upper, Headache, Vomiting
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain upper, headache (What is headache?), vomiting on Apr 29, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 180.0 lb, was diagnosed with blood cholesterol increased and. Vytorin dosage: One Tablet Daily At Bedtime Po.

6702239-9 | Breast Cancer, Joint Swelling, Oedema Peripheral, Swelling Face, Swollen Tongue
Adverse event was reported on Apr 23, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 79 years of age, Patient had the following side effects: breast cancer (What is breast cancer?), joint swelling, oedema peripheral, swelling face, swollen tongue. During the same period patient was treated with ZEGERID (View Zegerid Review and Zegerid Label ).

6700723-5 | Blood Amylase Increased, Lipase Increased
on Apr 26, 2010 Female patient from UNITED STATES , 55 years of age, weighting 108.0 lb, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: blood amylase increased, lipase increased. Vytorin dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6698072-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blood Creatine Phosphokinase Increased
on Apr 26, 2010 Female patient from UNITED STATES , 59 years of age, weighting 143.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood creatine phosphokinase increased. Vytorin dosage: Qd. During the same period patient was treated with WARFARIN SODIUM (Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6690515-8 | Compartment Syndrome
Patient was taking Vytorin (View Usage). Patient had the following side effects: compartment syndrome on Apr 16, 2010 from GERMANY Additional patient health information: Male patient , 60 years of age, weighting 253.5 lb, was diagnosed with hypercholesterolaemia, hypertension, hyperuricaemia and. Vytorin dosage: . During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.